NanoViricides, Inc.

NNVC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Dec 27, 2012 CURRENT REPORT
424B5 Dec 27, 2012 PROSPECTUS SUPPLEMENT
EFFECT Dec 21, 2012
CORRESP Dec 20, 2012
CORRESP Dec 20, 2012
DEF 14A Dec 4, 2012 DEF 14A
S-3/A Dec 3, 2012 AMENDMENT TO S-3
10-Q Nov 19, 2012 FORM 10-Q
NT 10-Q Nov 14, 2012 FORM 12B-25
UPLOAD Nov 5, 2012
S-3 Oct 26, 2012 FORM S-3
10-K/A Oct 26, 2012 FORM 10-K/A
10-K Oct 15, 2012 FORM 10-K
NT 10-K Sep 28, 2012 NOTICE UNDER RULE 12B25
UPLOAD Jul 10, 2012
8-K/A Jul 2, 2012 AMENDMENT TO FORM 8-K
8-K Jun 29, 2012 8-K CURRENT REPORT
424B5 Jun 28, 2012 424B5
10-Q/A Jun 14, 2012 AMENDMENT TO FORM 10-Q
10-Q/A Jun 14, 2012 AMENDMENT TO FORM 10-Q
10-K/A Jun 14, 2012 AMENDMENT TO FORM 10-K
CORRESP Jun 11, 2012
CORRESP May 30, 2012
10-Q May 21, 2012 QUARTERLY REPORT
NT 10-Q May 15, 2012 NOTIFICATION OF LATE FILING
← Newer Page 14 of 23 · 558 filings Older →